A Clinical Overview for Medical Professionals | Official Iranian Representative of IPP Russia
Among the questions most frequently raised by clinicians considering the integration of non-linear diagnostics into their practice, one stands above all others: How, precisely, does this system work?
The Metatron NLS (Non-Linear System) — developed by the Institute of Practical Psychophysics (IPP), Omsk, Russia, under the scientific direction of Academician Vladimir Nesterov — represents a diagnostic platform grounded in a theoretical framework that extends beyond conventional bioelectrical measurement. This article provides a structured, layered explanation of the system’s operating principles, from its biophysical foundations to its software architecture and clinical workflow, as documented in the official Metapathia GR Hospital technical manual (IPP, version 4.0, 2019).


The Biophysical Foundation: Torsion Fields and Biological Systems
To understand NLS diagnostics, one must first engage with the theoretical model proposed by IPP researchers. According to this model — developed within what IPP designates as quantum entropic logic theory — biological systems operate not only through biochemical and bioelectrical pathways, but also through a class of physical fields known as torsion fields.
In contemporary physics, four states of matter are recognized (solid, liquid, gas, plasma), alongside electromagnetic and gravitational fields. Torsion fields, as described by IPP, constitute a sixth level of physical reality — generated not by charge or mass, but by spin, the intrinsic angular momentum of rotating systems. Any rotating object, from a subatomic particle to a complex macromolecule, theoretically produces a torsion field with distinct properties:


Information Transfer
Transfer of information occurs without energy dissipation across any distance.
Penetration
Not shielded by conventional electromagnetic barriers or known environments.
Self-Organization
Dynamic structures emerge and adapt autonomously, maintaining coherence and stability.
Within this framework, the human body is conceptualized as a highly complex spin system. The torsion field of an organism reflects the totality of biochemical dynamics occurring across tissues, organs, and cellular structures. Crucially, IPP’s research posits a close correlation between torsion field parameters and the functional state of biological systems — meaning that pathological changes at the tissue or cellular level alter the measurable torsion field profile of the affected organ.


The Role of DNA and Cellular Communication
A second pillar of the theoretical framework concerns intracellular and intercellular signaling. IPP researchers propose that DNA molecules, chromosomes, and proteins function as coherent emitters — analogous in principle to laser systems — capable of generating and receiving electromagnetic and torsion field signals.
This model suggests that a significant portion of genetic information is stored in the chromosomal apparatus in the form of holograms, allowing system-wide instantaneous informational access. The clinical implication is significant: pathological disruption of this wave communication — whether caused by infectious agents, metabolic disturbance, toxicity, or structural degeneration — produces a detectable shift in the organism’s torsion-field signature before it manifests as a measurable change in conventional biochemical or imaging parameters.
This is the theoretical basis on which the Metatron NLS system claims early-stage functional assessment capability.


Signal Detection: The Trigger Gauge and Neurocortical Amplification
The central instrumentation challenge in NLS diagnostics is converting the sub-threshold torsion field signals of biological tissues into a measurable, processable data stream. The Metatron system addresses this through a two-stage mechanism.
Neurocortical Amplification
Magnetic inductors placed on the patient's temporal regions interact with the neurocytes of the cerebral cortex. Spin frames of delocalized electrons enter metastable states; their disintegration amplifies the initiation signal via a resonant electronic oscillator array tuned to tissue-specific wavelengths.
Digital Trigger Gauge
A proprietary digital trigger gauge captures amplified fluctuations, filters them against statistical noise, and converts the analog signal into a digital sequence. This is transmitted for mathematical reconstruction as a functional tissue map.
The system operates across a frequency histogram spanning 1.8 to 8.2 Hz — the range within which biological tissue oscillations have been characterized in IPP’s experimental database. The brain itself serves as a biological amplifier, selectively enhancing signals that would otherwise be indistinguishable from statistical noise.
Spectral-Entropic Analysis: Quantifying Tissue State
The computational core of the Metatron system is Spectral-Entropic Analysis (SEA) — the algorithmic process by which raw signal data is translated into a clinically interpretable assessment of tissue condition. The entropy value of any biological system is represented on a color spectrum:
Entropy Scale Interpretation
Functional and Organic Tissue Assessment
For each examined organ or tissue, the system computes a spectral similarity coefficient — a numerical value expressing the degree of match between the patient’s recorded oscillation profile and the reference profiles stored in the system’s database. This database encompasses healthy tissue profiles, pathological process profiles at multiple stages, infectious agent spectral signatures, and drug/supplement spectral profiles for compatibility assessment.
A spectral difference coefficient below 0.425 indicates high similarity to a pathological process and triggers automatic flagging in the SmartReport module.


Visualization: From Signal to 4D Clinical Image
Raw spectral-entropic data is rendered into clinical images through IPP’s proprietary 4D Tissue technology. This pipeline produces:
3D Anatomical Models
Volumetric organ models viewable from any orientation with color-coded entropy overlay.
Ultrastructure Drilling
Sequential examination from organ level → histological section → cytology → chromosomal apparatus → DNA fragment.
3D Scanning Mode
Automated pathology localization from macro anatomy to the genomic level. Designed for oncological and genetic disease assessment.
Deep Vision
Visualization of internal structures normally obscured by overlying anatomy — selectively rendered.
The examination cycle ranges from 1.5 minutes to 1.5 hours, depending on examination depth selected. Results are exported as PDF reports and retained in the patient database for longitudinal comparative analysis.
The Metatron NLS Diagnostic Hierarchy
Express Protocol
Complete topographic scan of selected systems. Color-coded functional overview. Suitable for initial screening and triage.
Standard Protocol
Detailed evaluation of structures showing pathological signal deviation. Includes histological correlation.
Detailed Protocol
Full evaluation of all biological formations including ultrastructure. Basis for differential diagnostic assessment.
Beyond diagnostic protocols, the system includes two additional functional modes. Vegeto-Test mode performs electromagnetic resonance testing of therapeutic agents against the patient’s individual spectral profile — intended to assess anticipated individual response prior to prescription. Meta-therapy mode applies modulated oscillations intended to counteract detected disharmonic frequencies, based on the MoRa method developed by Morel and Rasche in the 1970s and extended by IPP.


Patient Data Entry
Age, sex, blood group, Rh factor, and any available laboratory results integrated into the patient record.
Magnetic Inductor Placement
Left temporal (L) and right temporal (R) with polarity adherence. Non-invasive, contactless procedure.
Protocol Selection
Clinician selects Express, Standard, or Detailed examination depth based on clinical objective.
Automated Scanning
System runs autonomously with real-time 4D visualization on-screen. Clinician monitors organ-by-organ progress.
SEA Processing & Database Matching
Spectral similarity coefficients computed and matched against IPP reference database of healthy and pathological profiles.
SmartReport Generation
Auto-selection of significantly changed organs. Preliminary epicrisis and drug compatibility assessment generated.
Physician's Conclusion & PDF Export
Clinician adds written conclusion. Final report exported to PDF for patient record and external sharing.
Longitudinal Monitoring
Comparative analysis module tracks functional changes across serial examinations over time.
Intended Clinical Applications & Regulatory Framework
As documented in the official technical specifications, the Metatron NLS system is indicated for:
Functional Screening
Organ and system status assessment with probabilistic localization of dysfunction loci.
Differential Diagnosis
Generation of provisional diagnostic hypotheses for clinical follow-up and confirmation.
Treatment Monitoring
Longitudinal assessment of functional change dynamics under therapeutic intervention.
Homeostasis Assessment
Evaluation of psycho-emotional state and basic biosystem homeostasis parameters.


Contraindications as specified: patients under 7 years of age, epilepsy, active psychiatric disorders, hyperthermia above 38°C, recent myocardial infarction or stroke, pregnancy, implanted cardiac pacemakers, and presence of metallic implants or endoprostheses.
Quality System
EN ISO 13485:2003 + AC:2009
EU Medical Directive
MDD 93/42/EEC — CE Compliance
RF Patent
No. 200161075 (priority 2001)
US Patents
US 6,549,805 B1 · US 2010/0081959 A1
EMC Compliance
CISPR 11 · Class B, Group 1
Device Class
Type B Applied Part · Safety Class IIa
This article is based on the official Metapathia GR Hospital User Manual, Version 4.0 (IPP, 2019), and the technical documentation of the Metatron-4025 Clinical system. The theoretical frameworks described — including torsion field theory and quantum entropic logic — reflect the scientific model of the Institute of Practical Psychophysics. Medical professionals seeking clinical trial data, device demonstration appointments, or the complete IPP research bibliography are invited to contact our office directly.



No comment